glp 1 agonist definition America's Poison Centers What is GLP-1 & Does

2011 May;19(5):985-93

Afterwards, follow your originally planned injection schedule

Yes, switching is straightforward because its the same medication

Nevertheless, future clinical randomized trial is warranted to determine the effectiveness of currently used therapies

The TRIUMPH-4 Phase 3 data provides the most current safety information: Nausea: 38.1% (9 mg) to 43.2% (12 mg) versus 10.7% placebo Diarrhea: 34.7% (9 mg) to 33.1% (12 mg) versus 13.4% placebo Constipation: 21.8% (9 mg) to 25.0% (12 mg) versus 8.7% placebo Vomiting: 20.4% (9 mg) to 20.9% (12 mg) versus 0% placebo Decreased appetite: 19.0% (9 mg) to 18.2% (12 mg) versus 9.4% placebo The pattern is clear

M., Gratzl S., et al., Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity, JAMA Internal Medicine 184 (2024): 10561064